Strategies to Prevent Cardiovascular Toxicity in Breast Cancer: Is It Ready for Primetime?
Repository Usage Stats
Cardio-oncology is an emerging field tasked with identifying and treating cancer therapy related cardiac dysfunction (e.g., cytotoxic agents, immunotherapies, radiation, and hormone therapies) and optimizing the cardiovascular health of cancer patients exposed to these agents. Novel cancer therapies have led to significant improvements in clinical outcomes for breast cancer patients. In this article, we review the current literature on assessing cardiovascular risk of breast cancer therapies and discuss strategies (including pharmacological and lifestyle interventions) to prevent cardiovascular toxicity.
Published Version (Please cite this version)10.3390/jcm9040896
Publication InfoKikuchi, Robin; Shah, Nishant P; & Dent, Susan F (2020). Strategies to Prevent Cardiovascular Toxicity in Breast Cancer: Is It Ready for Primetime?. Journal of clinical medicine, 9(4). 10.3390/jcm9040896. Retrieved from https://hdl.handle.net/10161/20292.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
More InfoShow full item record
Instructor in the Department of Medicine
Medical Oncologist with a focus on breast cancerAssociate Director of Breast Cancer Clinical ResearchCo-Director Duke Cardio-Oncology Program
Assistant Professor of Medicine
Alphabetical list of authors with Scholars@Duke profiles.